dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Felip Font, Enriqueta |
dc.contributor.author | Ardizzoni, Andrea |
dc.contributor.author | Ciuleanu, Tudor |
dc.contributor.author | Laktionov, Konstantin |
dc.contributor.author | Szilasi, Maria |
dc.contributor.author | Cobo, Manuel |
dc.date.accessioned | 2021-10-22T08:01:22Z |
dc.date.available | 2021-10-22T08:01:22Z |
dc.date.issued | 2020-03-01 |
dc.identifier.citation | Felip E, Ardizzoni A, Ciuleanu T, Cobo M, Laktionov K, Szilasi M, et al. CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations. Eur J Cancer. 2020 Mar 1;127:160–72. |
dc.identifier.issn | 0959-8049 |
dc.identifier.uri | https://hdl.handle.net/11351/6443 |
dc.description | Gent gran; Nivolumab; Càncer de pulmó de cèl·lules no petites |
dc.description.sponsorship | Funded by Bristol-Myers Squibb. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | European Journal of Cancer;127 |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Persones grans |
dc.subject | Pulmons - Càncer - Quimioteràpia |
dc.subject.mesh | Carcinoma, Non-Small-Cell Lung |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Aged |
dc.title | CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.ejca.2019.11.019 |
dc.subject.decs | carcinoma de pulmón de células no pequeñas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | anciano |
dc.relation.publishversion | https://doi.org/10.1016/j.ejca.2019.11.019 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Felip E] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Ardizzoni A] Division of Medical Oncology, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, 40138, Italy. [Ciuleanu T] The Oncology Institute Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, RO-400015, Romania. [Cobo M] Hospital Regional Universitario de Málaga and IBIMA, Malaga, 29010, Spain. [Laktionov K] N.N. Blokhin Russian Cancer Research Center, Moscow, 115478, Russia. [Szilasi M] University of Debrecen, Department for Pulmonology, Debrecen, H-4032, Hungary |
dc.identifier.pmid | 32028209 |
dc.identifier.wos | 000514572100017 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |